Announced
Completed
Eris Lifesciences completed the acquisition of a 70% stake in Swiss Parenterals for $105m.
Financials
Transaction Value£83m
Consideration TypeCash
Capital Owned-
Capital Bid For70%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
India
sterile pharmaceuticals
Pharmaceuticals
Acquisition
Domestic
Majority
Private
Friendly
Single Bidder
Completed
Synopsis
Eris Lifesciences, an Indian branded formulations company, completed the acquisition of a 70% stake in Swiss Parenterals, a progressing dynamic pharmaceutical manufacturing company, for $105m.
Amit Bakshi
Chairman and Managing Director at ERIS LIFESCIENCESDeal Bio
Total Deals
6/Total Value
£248MSearch a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.